A proposed update to ATF Form 4473 could change how medical marijuana is addressed during firearm purchases from federally licensed dealers. The revision follows the Trump administration’s move to reschedule certain medical marijuana products and remove older language that treated medical and recreational cannabis the same way.
For patients, gun owners, and medical cannabis advocates, the issue is not simple. The medical marijuana question now sits in a more nuanced legal space. The form still asks about unlawful drug use, but the proposed wording now draws a clearer line around recreational marijuana.
What ATF Is Proposing To Change On Form 4473
ATF is proposing a revised version of Form 4473, the form you complete when buying a gun from a federally licensed firearms dealer. The current form asks whether you are an unlawful user of, or addicted to, marijuana or another controlled substance.
The older warning says marijuana use or possession remains unlawful under federal law, even if your state has legalized or decriminalized it for medical or recreational purposes. That wording treats state medical marijuana patients the same as recreational cannabis users for purposes of the form.
The proposed form changes that message. Instead of naming medical marijuana in the warning, it says federal law does not permit marijuana use or possession for recreational purposes. That wording matters because it leaves out the prior warning about medical cannabis and reflects the administration’s recent rescheduling move for certain medical marijuana products.
Why Medical Marijuana Is Treated Differently In The Draft Form
The proposed change is likely tied to an order from Acting Attorney General Todd Blanche. That order moved marijuana products regulated by a state medical cannabis license to Schedule III of the Controlled Substances Act, meaning cannabis is now Schedule III in that context. It also rescheduled marijuana products approved by the Food and Drug Administration.
That shift is important because Schedule III drugs are treated differently from substances placed in more restrictive categories. The Congressional Research Service reviewed the current rescheduling move and said certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III.
For you, the key point is that the proposed Form 4473 no longer appears to describe medical marijuana use or possession as automatically disqualifying in the same way the older form did. The revised warning focuses on recreational marijuana, not state-regulated medical cannabis.
What The New Attestation Would Say
The proposed form would still require gun buyers to answer a controlled substance question. ATF is not removing the issue from the form. Instead, it is changing the wording of the attestation and warning.
The draft statement says you are not an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or other controlled substance. It also warns that you can still be an unlawful user under federal law, even if possession is legal under state law.
The most important wording changes include:
- The new warning removes the old reference to medical marijuana
- The revised language names recreational marijuana as federally prohibited
- The form still addresses unlawful controlled substance use
- State legality alone does not settle the federal question
- Public comments on the revised form are open through July 7
This means the proposal narrows the language, but it does not erase every legal concern.
Why This Matters For Medical Marijuana Patients
If you are a medical marijuana patient, this proposed change may feel significant because federal firearm forms have long created confusion and concern. The older language clearly warned that marijuana remained unlawful under federal law regardless of state medical marijuana laws. That placed patients in a difficult position when medical cannabis was legal in their state, but still treated harshly under federal law.
The revised ATF gun form signals a different approach. By leaving out medical cannabis and focusing the warning on recreational marijuana, ATF appears to recognize the administration’s Schedule III treatment of certain medical marijuana products.
Still, the legal picture remains active. A broader cannabis rescheduling hearing is scheduled for the summer. The Department of Justice is also reviewing how it defends certain firearm restrictions tied to marijuana and other drug use. So, while the draft form is meaningful, it sits inside a larger legal debate.
The Public Comment Period Gives You A Voice
ATF is accepting public comments on the revised gun purchase form through July 7. That matters because proposed administrative changes often depend on public feedback before a final version is adopted.
If this issue affects you as a patient, firearm owner, caregiver, business owner, or advocate, the comment period gives you a chance to respond to the proposed wording. You do not need to treat the draft form as final. The ATF posted a proposed revision, meaning the language is still under review.
Public comments can help explain how the form language affects real people. Patients may want clearer wording. Firearms groups may want the form revised further. Medical cannabis supporters may want federal agencies to separate state-regulated medical use from recreational cannabis more clearly. The July 7 deadline gives the public a defined window to speak.
Begin Your Medical Marijuana Journey With DocMJ
At DocMJ, we provide medical marijuana evaluations with licensed physicians who review your health history, discuss your qualifying condition, and explain the certification process. We help patients follow state medical cannabis requirements with clarity and confidence. Schedule your consultation today!
Aaron Bloom, an experienced healthcare attorney, serves as the CEO of DocMJ and Medwell Health and Wellness Centers, where he has overseen the organizations’ mission and growth since 2016. In addition to his leadership roles, Aaron serves on the Board of Directors for Waterfall Bank, bringing his expertise in healthcare, compliance, and strategic growth to the financial services sector.
Aaron’s passion for improving patients’ lives stems from more than 20 years of owning, operating, and representing traditional healthcare organizations. Throughout his career, he has remained committed to finding better ways to relieve suffering and expand access to innovative, patient-centered care. As CEO, Aaron works each day to help patients achieve better health and wellness through the therapeutic benefits of medical cannabis and other evidence-based alternative medicines.